Finance

Lists
Why is 603168 up 10.05%?
Dive Deeper
603168:SHA
Zhejiang Shapuaisi Pharmaceutical Co Ltd
CN¥6.24
+10.05%
(+0.57) 1D
Oct 16, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603168...
Open
CN¥5.72
High
CN¥6.24
Low
CN¥5.72
Mkt. cap
2.19B
Avg. vol.
7.24M
Volume
23.44M
52-wk high
CN¥8.81
52-wk low
CN¥4.55
EPS
-CN¥0.66
Shares outstanding
322.59M
No. of employees
1K
Open
CN¥5.72
High
CN¥6.24
Low
CN¥5.72
Mkt. cap
2.19B
Avg. vol.
7.24M
Volume
23.44M
52-wk high
CN¥8.81
52-wk low
CN¥4.55
EPS
-CN¥0.66
Shares outstanding
322.59M
No. of employees
1K
News stories
From web sources and news partners
About Zhejiang Shapuaisi Pharmaceutical Co Ltd
CEO-
Employees1.14K
FoundedJul 17, 2000
Headquarters-
SectorPharmaceutical industry
Websitezjspas.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
114.54M
112.15M
98.52M
97.98M
Cost of goods sold
66.48M
104.99M
48.48M
46.38M
Cost of revenue
66.48M
104.99M
48.48M
46.38M
Research and development expenses
3.09M
10.34M
4.64M
4.58M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
52.26M
44.72M
38.58M
67.59M
Operating expense
55.87M
62.85M
43.58M
73.78M
Total operating expenses
122.34M
167.84M
92.06M
120.16M
Operating income
-7.80M
-55.69M
6.46M
-22.18M
Other non operating income
-1.14M
1.53M
-125.58K
99.16K
EBT including unusual items
3.94M
-265.30M
-25.81M
49.83M
EBT excluding unusual items
12.45M
-51.48M
4.49M
-14.35M
Income tax expense
-1.83M
1.06M
289.14K
4.23M
Effective tax rate
-46.50%
-0.40%
-1.12%
8.48%
Other operating expenses
-3.86M
6.67M
6.62K
1.62M
Net income
5.77M
-266.35M
-26.10M
45.60M
Net profit margin
5.04%
-237.49%
-26.50%
46.54%
Earnings per share
-
-
-
-
Interest and investment income
23.03M
5.71M
20.69K
9.89M
Interest expense
-1.63M
-3.03M
-1.86M
-2.16M
Net interest expenses
21.40M
2.68M
-1.84M
7.73M
Depreciation and amortization charges
-
-
-
-
EBITDA
8.18M
-39.60M
22.55M
-8.00M
Gain or loss from assets sale
646.17K
-903.28K
-
-3.01M
AI content may include mistakes. Learn more
Google apps